Skip to main content

Shivani Grover, MS

Shivani Grover, MS

Shivani Grover, MS

Shivani Grover, MS, is a research associate scientist with the Mitochondrial Medicine Frontier Program at Children’s Hospital of Philadelphia.


267-426-4961

About Shivani Grover, MS

Titles

Research Associate Scientist I

Education & training

Undergraduate Degree

Bachelor of Technology in Bioinformatics - Dr. D.Y. Patil University, Mumbai, India

Graduate Degree

MS in Biological Sciences - Virgina Tech, Blacksburg, VA

Team affiliations

View fewer all team affiliations View all all team affiliations

Publications

Publications

2023

Morini, E., Chekuri, A., Logan, E. M., Bolduc, J. M., Kirchner, E. G., Salani, M., Krauson, A. J., Narasimhan, J., Gabbeta, V., Grover, S., Dakka, A., Mollin, A., Jung, S. P., Zhao, X., Zhang, N., Zhang, S., Arnold, M., Woll, M. G., Naryshkin, N. A., Weetall, M., Slaugenhaupt, S. A. (2023). Development of an oral treatment that rescues gait ataxia and retinal degeneration in a phenotypic mouse model of familial dysautonomia. American journal of human genetics, 110(3), 531–547. https://doi.org/10.1016/j.ajhg.2023.01.019.

Morini, E., Chekuri, A., Logan, E. M., Bolduc, J. M., Kirchner, E. G., Salani, M., Krauson, A. J., Narasimhan, J., Gabbeta, V., Grover, S., Dakka, A., Mollin, A., Jung, S. P., Zhao, X., Zhang, N., Zhang, S., Arnold, M., Woll, M. G., Naryshkin, N. A., Weetall, M., Slaugenhaupt, S. A. (2023). Development of an oral treatment that rescues gait ataxia and retinal degeneration in a phenotypic mouse model of familial dysautonomia. bioRxiv 2022.11.04.515198. https://doi.org/10.1101/2022.11.04.515198.

2017

Grover, S., & Lawrence, C. B. (2017). The Alternaria alternata Mycotoxin Alternariol Suppresses Lipopolysaccharide-Induced Inflammation. International journal of molecular sciences, 18(7), 1577. https://doi.org/10.3390/ijms18071577.

2015

Shivani Grover, Brad Howard and Christopher Lawrence; The fungal secondary metabolite alternariol and Alternaria induced immunity (MPF6P.659). J Immunol May 1, 2015, 194 (1 Supplement) 202.17 [Conference].

Jump back to top